Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: T
Results 1 - 10 of 502 shown below

  • T cell activation

    E Tartour, M Mehtali, X Sastre-Garau, I Joyeux, C Mathiot, J M Pleau, P Squiban, C Rochlitz, M Courtney, P Jantscheff, R Herrmann, P Pouillart, W H Fridman and T Dorval

    Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings

    doi:10.1054/bjoc.2000.1492

  • T cells

    J J French, J Cresswell, W K Wong, K Seymour, R M Charnley and J A Kirby

    T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?

    doi:10.1038/sj.bjc.6600597

  • A Kiessling, S Stevanovic, S Füssel, B Weigle, M A Rieger, A Temme, E P Rieber and M Schmitz

    Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein

    doi:10.1038/sj.bjc.6601642

  • J C Steele, C H Mann, S Rookes, T Rollason, D Murphy, M G Freeth, P H Gallimore and S Roberts

    T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia

    advance online publication, 2005-06-28 00:00:00.000;

    doi:10.1038/sj.bjc.6602679

  • D J Gottlieb, Y-C Li, I Lionello, S Tanzarella, M Marangolo, K F Bradstock, V Russo and C Traversari

    Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma

    advance online publication, 2006-07-04 00:00:00.000;

    doi:10.1038/sj.bjc.6603243

  • E Kabingu, L Vaughan, B Owczarczak, K D Ramsey and S O Gollnick

    CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells

    advance online publication, 2007-05-15 00:00:00.000;

    doi:10.1038/sj.bjc.6603792

  • T lymphocyte

    A J Sheen, D J Sherlock, J Irlam, R E Hawkins and D E Gilham

    T lymphocytes isolated from patients with advanced colorectal cancer are suitable for gene immunotherapy approaches

    doi:10.1038/sj.bjc.6600857

  • T lymphocytes

    D D Taylor and C Gerçel-Taylor

    Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects

    advance online publication, 2005-01-18 00:00:00.000;

    doi:10.1038/sj.bjc.6602316

  • E Reyes, I García-Castro, F Esquivel, J Hornedo, H Cortes-Funes, J Solovera and M Alvarez-Mon

    Granulocyte colony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative response

    doi:10.1038/sj.bjc.6690344

  • TbetaRII

    G Anumanthan, S K Halder, H Osada, T Takahashi, P P Massion, D P Carbone and P K Datta

    Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells

    advance online publication, 2005-10-25 00:00:00.000;

    doi:10.1038/sj.bjc.6602831

  • TbetaRII

    S Y Leung and J C I Ho

    Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor beta receptor and BAX in gastric carcinomas in Hong Kong Chinese

    doi:10.1038/sj.bjc.6690092

  • t(14;18)

    P Soubeyran, I Hostein, M Debled, H Eghbali, I Soubeyran, F Bonichon, T Astier-Gin and B Ho eligrni

    Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas

    doi:10.1038/sj.bjc.6690777

  • t(8;21)

    H Matsushita, M Kizaki, H Kobayashi, A Muto and Y Ikeda

    Induction of apoptosis in myeloid leukaemic cells by ribozymes targeted against AML1/MTG8

    doi:10.1038/sj.bjc.6690214

  • T-cell

    I Yamato, M Sho, T Nomi, T Akahori, K Shimada, K Hotta, H Kanehiro, N Konishi, H Yagita and Y Nakajima

    Clinical importance of B7-H3 expression in human pancreatic cancer

    advance online publication, 2009-10-20 00:00:00.000;

    doi:10.1038/sj.bjc.6605375

  • R S Selvan, T N Pappas and F E Ward

    Lack of evidence for MHC-unrestricted (atypical) recognition of mucin by mucinous pancreatic tumour-reactive T-cells

    doi:10.1054/bjoc.1999.0982

  • T-cell activation

    J B Bartlett, A Michael, I A Clarke, K Dredge, S Nicholson, H Kristeleit, A Polychronis, H Pandha, G W Muller, D I Stirling, J Zeldis and A G Dalgleish

    Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers

    doi:10.1038/sj.bjc.6601579